Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, Peter G., Kauffman, Carol A., Andes, David, Benjamin, Daniel K., Calandra, Thierry F., Edwards, John E., Filler, Scott G., Fisher, John F. +6 more·2009·Clinical Infectious Diseases

Cited by (1,018)

Items 601–700 of 1,018

  1. A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients
    Donald I. Hsu, M. Nguyen, L. Nguyen, Anandi V. Law, Annie Wong‐Beringer · 2010 · Journal of Antimicrobial Chemotherapy
  2. (1–3)-β-D-Glucan Assay: A Review of its Laboratory and Clinical Application
    William F. Wright, Sue B. Overman, Julie A. Ribes · 2011 · Laboratory Medicine
  3. Epidemiology of Oropharyngeal Candidiasis in Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients and CD4+ Counts.
    Antoine Berbéri, Ziad Noujeim, Georges Aoun · 2015 · PubMed Central
  4. Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection
    Marco Falcone, Alessandro Russo, Federica Iraci, Paolo Carfagna, Paola Goldoni, Vincenzo Vullo, Mario Venditti · 2015 · Antimicrobial Agents and Chemotherapy
  5. A Clinician’s Guide to the Diagnosis and Treatment of Candidiasis in Patients with Psoriasis
    April Wang Armstrong, Michael Bukhalo, Andrew Blauvelt · 2016 · American Journal of Clinical Dermatology
  6. Liver Transplantation in Acute-on-chronic Liver Failure
    Constantine Jason Karvellas, Claire Francoz, Emmanuel Weiss · 2020 · Transplantation
  7. Rate of<i>FKS</i>Mutations among Consecutive Candida Isolates Causing Bloodstream Infection
    Shields, Ryan K., Nguyen, M. Hong, Press, Ellen G., Cumbie, Richard, Driscoll, Eileen, Pasculle, A. William, Clancy, Cornelius J. · 2015 · Antimicrobial Agents and Chemotherapy
  8. An Evaluation of Hepatotoxicity and Nephrotoxicity of Liposomal Amphotericin B (L-AMB)
    Gourang P. Patel, Christopher W. Crank, Jerrold Blair Leikin · 2010 · Journal of Medical Toxicology
  9. Photodynamic fungicidal efficacy of hypericin and dimethyl methylene blue against azole‐resistant Candida albicans strains
    Manuel Pablo Paz-Cristobal, Diego Royo, Antonio Rezusta, Elena Andres-Ciriano, M. C. Alejandre, Jacques F. G. M. Meis, Ma José Revillo, Carmen Aspíroz, Santi Nonell, Yolanda Gilaberte · 2013 · Mycoses
  10. The Economic Impact of Rapid Candida Species Identification by T2Candida Among High-Risk Patients
    Sara Pinar Bilir, Cheryl P Ferrufino, Michael A. Pfaller, Julie Munakata · 2015 · Future Microbiology
  11. Prophylaxis and Treatment of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Results of a Consensus Process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
    Corrado Girmenia, Giovanni Barosi, Franco Aversa, Andrea Paolo Bacigalupo, Tiziano Barbui, DONATELLA BARONCIANI, Alberto Bosi, Anna Candoni, Anna Locasciulli, Franco Locatelli et al. · 2009 · Clinical Infectious Diseases
  12. Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis
    Hong Liao, Shanling Liu, He Wang, Hang Su, Zhenjun Liu · 2019 · BMC Microbiology
  13. Antifungal resistance in patients with Candidaemia: a retrospective cohort study
    Namareq Fahad Aldardeer, Hadiel Albar, Majda Alattas, Abdelmoneim Eldali, Mohammed Qutub, Ashraf Hassanien, Basem M. Alraddadi · 2020 · BMC Infectious Diseases
  14. Candida Peritonitis: An Update on the Latest Research and Treatments
    Herman Anthony Carneiro, Anastasios Mavrakis, Eleftherios E Mylonakis · 2011 · World Journal of Surgery
  15. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China
    Liu, Jin-Yan, Shi, Ce, Wang, Ying, Li, Wen-Jing, Zhao, Yue, Xiang, Ming-Jie · 2015 · Research in Microbiology
  16. Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study
    Gerardo Aguilar, Carlos Delgado, Isabel Corrales, Ana Córdoba Izquierdo, Estefanía Gracia, Tania Moreno, Esther Romero, Carlos Ferrando, J Carbonell, Rafael Borrás et al. · 2015 · BMC Research Notes
  17. Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
    Mario Fernández‐Ruiz, Mireia Puig‐Asensio, Jesús Guinea, Benito Almirante, Belén Padilla, Manuel Almela, Ana Díaz‐Martín, Jesús Rodríguez‐Baño, Manuel Cuenca‐Estrella, José María Aguado · 2015 · Journal of Infection
  18. Infecciones relacionadas con el uso de los catéteres vasculares
    Carmen Ferrer, Benito Almirante · 2014 · Enfermedades Infecciosas y Microbiología Clínica
  19. Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis
    Jodi M. Lestner, Susan Julie Howard, Joanne Goodwin, Lea Gregson, Jayesh B. Majithiya, Thomas J. Walsh, Gerard M. Jensen, William W. Hope · 2010 · Antimicrobial Agents and Chemotherapy
  20. Current strategies for the prevention and management of central line-associated bloodstream infections
    Jonas Marschall · 2010 · Infection and Drug Resistance
  21. Comparative Analysis of the Capacity of the Candida Species To Elicit Vaginal Immunopathology
    H. Willems, David J. Lowes, K. Barker, Glen E. Palmer, B. Peters · 2018 · Infection and Immunity
  22. Review of the Novel Echinocandin Antifungal Rezafungin: Animal Studies and Clinical Data
    Yanan Zhao, David S. Perlin · 2020 · Journal of Fungi
  23. Candida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance
    Fleischer C. N. Kotey, Nicholas T. K. D. Dayie, Patience B. Tetteh‐Quarcoo, Eric S. Donkor · 2021 · Infectious Diseases Research and Treatment
  24. Nephrotoxicity Associated With Amphotericin B Deoxycholate in Neonates
    Jennifer Lê, Felice C. Adler‐Shohet, Christine P. Nguyen, Jay M. Lieberman · 2009 · The Pediatric Infectious Disease Journal
  25. Wound Care in the Neonatal Intensive Care Unit
    Miriam D. Fox · 2011 · Neonatal Network The Journal of Neonatal Nursing
  26. Micafungin Versus Amphotericin B Lipid Complex for the Prevention of Invasive Fungal Infections in High-Risk Liver Transplant Recipients
    Hsin‐Yun Sun, Thomas V. Cacciarelli, Nina Singh · 2013 · Transplantation
  27. Invasive Fungal Infections in the ICU
    Shmuel Shoham, Shilpa Marwaha · 2009 · Journal of Intensive Care Medicine
  28. The Role of Echinocandins in Candida Biofilm–Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems
    Mahmoud Afif Ghannoum, Emmanuel Roilides, Aspasia Katragkou, Vidmantas Petraitis, Thomas J. Walsh · 2015 · Clinical Infectious Diseases
  29. Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study
    Marco Falcone, Giusy Tiseo, Carlo Tascini, Alessandro Russo, Emanuela Sozio, Giammarco Raponi, Chiara Rosin, Pasquale Pignatelli, Paolo Carfagna, Alessio Farcomeni et al. · 2017 · European Journal of Internal Medicine
  30. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol
    Lírio, Juliana, Giraldo, Paulo Cesar, Amaral, Rose Luce, Sarmento, Ayane Cristine Alves, Costa, Ana Paula Ferreira, Gonçalves, Ana Katherine · 2019 · BMJ Open
  31. Attributable mortality of candidemia after introduction of echinocandins
    Florian B. Cornely, Oliver A. Cornely, Jon Salmanton‐García, Felix Carlo Koehler, Philipp A. Koehler, Harald Seifert, Sebastian Marcel Wingen-Heimann, Sibylle C. Mellinghoff · 2020 · Mycoses
  32. Fungemia Associated with Left Ventricular Assist Device Support
    Natasha Bagdasarian, Anurag N. Malani, Francis D. Pagani, Preeti Malani · 2009 · Journal of Cardiac Surgery
  33. Mediator Tail Module Is Required for Tac1-Activated <i>CDR1</i> Expression and Azole Resistance in Candida albicans
    Liu, Zhongle, Myers, Lawrence C. · 2017 · Antimicrobial Agents and Chemotherapy
  34. Chronic vulvovaginal candidiasis: What we know and what we have yet to learn
    Gayle O. Fischer · 2012 · Australasian Journal of Dermatology
  35. Diagnostic challenges and recent advances in the early management of invasive fungal infections
    Pranatharthi Haran Chandrasekar · 2009 · European Journal Of Haematology
  36. Exogenous Fungal Endophthalmitis: An Analysis of Isolates and Susceptibilities to Antifungal Agents Over a 20-Year Period (1990–2010)
    Ruwan Amila Silva, Jayanth S. Sridhar, Darlene Miller, Charles C. Wykoff, Harry W. Flynn · 2014 · American Journal of Ophthalmology
  37. Electronic Memorandum Decreases Unnecessary Antimicrobial Use for Asymptomatic Bacteriuria and Culture-Negative Pyuria
    Leslie A. Linares, David J. Thornton, Judith M. Strymish, Errol H. Baker, Kalpana Gupta · 2011 · Infection Control and Hospital Epidemiology
  38. Pharmacology and clinical use of voriconazole
    George R. Thompson, James S. Lewis · 2009 · Expert Opinion on Drug Metabolism & Toxicology
  39. Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin
    J. L. Slater, Susan Julie Howard, Joanne Sharp, Joanne Goodwin, Lea Gregson, Ana Alastruey‐Izquierdo, Maiken Cavling Arendrup, Peter A. Warn, David S. Perlin, William W. Hope · 2011 · Antimicrobial Agents and Chemotherapy
  40. Recomendaciones sobre el tratamiento de la enfermedad fúngica invasiva por Aspergillus spp. y otros hongos filamentosos de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2011
    Jesús Fortün, Jordi Carratalà, Joan Gavaldà, Manuel Lizasoaín, Miguel Salavert, Rafael de la Cámara, Marcío Borges-Sa, Carlos Cervera, José Garnacho, Álvaro Lassaleta et al. · 2011 · Enfermedades Infecciosas y Microbiología Clínica
  41. Cold atmospheric plasma inhibits the growth of Candida albicans by affecting ergosterol biosynthesis and suppresses the fungal virulence factors in vitro
    Neda Rahimi-Verki, Atena Shapoorzadeh, Mehdi Razzaghi‐Abyaneh, Seyed-Mohammad Atyabi, Masoomeh Shams‐Ghahfarokhi, Zahra Jahanshiri, Mohammadhassan Gholami‐Shabani · 2015 · Photodiagnosis and Photodynamic Therapy
  42. Miltefosine inhibits Candida albicans and non-albicans Candida spp. biofilms and impairs the dispersion of infectious cells
    Taissa Vieira Machado Vila, Kelly Ishida, Sérgio Henrique Seabra, Sônia Rozental · 2016 · International Journal of Antimicrobial Agents
  43. Clinical Recommendation: Vulvovaginitis
    Andrea L. Zuckerman, Mary Romano · 2016 · Journal of Pediatric and Adolescent Gynecology
  44. The Pitt Bacteremia Score, Charlson Comorbidity Index and Chronic Disease Score are useful tools for the prediction of mortality in patients with Candida bloodstream infection
    Mar�a Paz Vaquero-Herrero, Silvio Ragozzino, F. Castaño-Romero, María Siller, Rebeca Sánchez González, José Elías García‐Sánchez, María Inmaculada García‐García, Miguel Marcos, Hugo Guillermo Ternavasio‐de la Vega · 2017 · Mycoses
  45. Yeast species-specific, differential inhibition of β-1,3-glucan synthesis by poacic acid and caspofungin
    Keunsook K. Lee, Karen Kubo, Jehan Abdelmoneim Abdelaziz, Iain Cunningham, Alessandra de Silva Dantas, Xiaolin Chen, Hiroki Okada, Yoshikazu Ohya, Neil A. R. Gow · 2018 · The Cell Surface
  46. Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study
    Caitlin Keighley, S. C.- A. Chen, Deborah J. E. Marriott, Alun Lloyd Pope, Belinda Chapman, K. Kennedy, Narin Bak, N. Underwood, Heather L. Wilson, Kyle McDonald et al. · 2019 · BMC Infectious Diseases
  47. Candida colonization as a predictor of invasive candidiasis in non-neutropenic ICU patients with sepsis: A systematic review and meta-analysis
    Hameid Alenazy, Amenah Alghamdi, Ruxandra L Pinto, Nick Daneman · 2020 · International Journal of Infectious Diseases
  48. Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review
    Hazem Fathy Elewa, Eman Elmekaty, Ahmed El‐Bardissy, Mary H. H. Ensom, Kyle John Wilby · 2015 · Clinical Pharmacokinetics
  49. Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria
    Pfaller, Michael A., Diekema, Daniel J., Jones, Ronald N., Castanheira, Mariana · 2014 · Journal of Clinical Microbiology
  50. Th17 cells, Jobʼs syndrome and HIV: opportunities for bacterial and fungal infections
    Joshua D. Milner, Netanya Sandler Utay, Daniel C. Douek · 2010 · Current Opinion in HIV and AIDS
  51. Activities of Triazole-Echinocandin Combinations against Candida Species in Biofilms and as Planktonic Cells
    Athanasios Chatzimoschou, Aspasia Katragkou, Maria Simitsopoulou, Charalampos Antachopoulos, Elpiniki Georgiadou, Thomas J. Walsh, Emmanuel Roilides · 2011 · Antimicrobial Agents and Chemotherapy
  52. Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method
    Michael A. Pfaller, Ana Espinel‐Ingroff, Beatriz Bustamante, Rafael Cantón, Daniel J. Diekema, A. Fothergill, J. Fuller, Gloria María González, Josep Guarro, Cornelia Lass‐Flörl et al. · 2013 · Antimicrobial Agents and Chemotherapy
  53. Comparative Evaluation of Three Commercial Identification Systems Using Common and Rare Bloodstream Yeast Isolates
    Joseph Meletiadis, Michael Arabatzis, Maria Bompola, Konstantinos Tsiveriotis, Stavroula Hini, Efthymia A. Petinaki, Aristea Velegraki, Loukia Zerva · 2011 · Journal of Clinical Microbiology
  54. Anti-Biofilm Strategies: How to Eradicate Candida Biofilms?
    Anna Bink · 2011 · The Open Mycology Journal
  55. Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis
    Maria Inês da Rosa, Bruno Rodrigues Silva, Patrícia S. Pires, Fábio R. Silva, Napoleão C. Silva, Fábio R. Silva, Suéli Lummertz Souza, Kristian Madeira, Ana Paula Ronzani Panatto, Lídia Rosi Medeiros · 2012 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  56. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high‐risk liver transplantation recipients: A propensity score analysis
    Jesús Fortün, Alfonso Muriel, Pilar Martín‐Dávila, Miguel Montejo, Óscar Len, Julián Torre‐Cisneros, Jordi Carratalà, Patricia Muñóz, María Carmen Fariñas, Asunción Moreno et al. · 2015 · Liver Transplantation
  57. The Effect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine Wards
    Francesco Giuseppe De Rosa, Silvia Corcione, Claudia Filippini, Stefania Raviolo, Lucina Fossati, Chiara Montrucchio, Chiara Aldieri, Alessia Petrolo, Rossana Cavallo, Giovanni Di Perri · 2015 · PLoS ONE
  58. Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis
    Ken Chen, Qi Wang, Roy Alton Pleasants, Long Ge, Wei Liu, Kangning Peng, Suodi Zhai · 2017 · BMC Infectious Diseases
  59. Antifungal Drug Susceptibility of Candida Species Isolated from HIV-Positive Patients Recruited at a Public Hospital in São Luís, Maranhão, Brazil
    Analucia G. Terças, Sirlei Garcia Marques, Eduardo Buozi Moffa, Márcia Barros Alves, Conceição de Maria Pedrozo e Silva de Azevedo, Walter L. Siqueira, Cristina de Andrade Monteiro · 2017 · Frontiers in Microbiology
  60. Prevalence of, and risk factors for, hematogenous fungal endophthalmitis in patients with Candida bloodstream infection
    Hideaki Kato, Yukihiro Yoshimura, Yoshihiro Suido, Kazuo Ide, Yoshifumi Sugiyama, Kasumi Matsuno, Hideaki Nakajima · 2018 · Infection
  61. Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance
    Csaba Papp, Katica Kocsis, Renáta Tóth, László Bodai, Jesse R. Willis, Ewa Księżopolska, Nancy E. Lozoya‐Pérez, Csaba Vágvölgyi, Héctor Manuel Mora Montes, Toni Gabaldón et al. · 2018 · mSphere
  62. Current therapeutic approaches to fungal infections in immunocompromised hematological patients
    Livio Pagano, Morena Caira, Caterina Giovanna Valentini, Brunella Posteraro, Luana Fianchi · 2010 · Blood Reviews
  63. Fungal bloodstream infections in tertiary care hospitals in Colombia
    Jorge Alberto Cortés, Patricia Reyes, Carlos Gómez, Giancarlo Buitrago, Aura Lucía Leal · 2011 · Revista Iberoamericana de Micología
  64. Intra-abdominal candidiasis: the guidelines—forgotten non-candidemic invasive candidiasis
    Philippe Montravers, Hervé Dupont, Philippe Eggimann · 2013 · Intensive Care Medicine
  65. Candida Species in the Urinary Tract: Is it a Fungal Infection or Not?
    Vanessa Cordeiro Dias · 2020 · Future Microbiology
  66. Impact of tolerance to fluconazole on treatment response in <i>Candida albicans</i> bloodstream infection
    Levinson, Tal, Dahan, Alon, Novikov, Anna, Paran, Yael, Berman, Judith, Ben‐Ami, Ronen · 2021 · Mycoses
  67. Development of a Luminex-Based Multiplex Assay for Detection of Mutations Conferring Resistance to Echinocandins in Candida glabrata
    Cau Dinh Pham, Carol B. Bolden, Randall J. Kuykendall, Shawn R. Lockhart · 2013 · Journal of Clinical Microbiology
  68. Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999–2008
    Elliott Geoffrey Playford, Graeme R. Nimmo, Martyn H. Tilse, Tania Christine Sorrell · 2010 · Journal of Hospital Infection
  69. Opportunistic Fungi: A View to the Future
    Peter G. Pappas · 2010 · The American Journal of the Medical Sciences
  70. Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications
    Chris R. Stockmann, Jonathan E. Constance, Jessica K. Roberts, Jared A Olson, Elizabeth H. Doby, Krow Ampofo, Justin Stiers, Michael G. Spigarelli, Catherine M.T. Sherwin · 2014 · Clinical Pharmacokinetics
  71. Combination antifungal therapy for invasive fungal infections in children and adults
    Nevin Hatipoğlu, Hüsem Hatipoğlu · 2013 · Expert Review of Anti-infective Therapy
  72. How much European prescribing physicians know about invasive fungal infections management?
    Maricela Valerio, Antonio Vena, Emilio Bouza, Nanna Reiter, Pierluigi Viale, Marcel Hochreiter, Maddalena Giannella, Patricia Muñóz, on behalf the COMIC study group (Collaborative group on Mycosis) · 2015 · BMC Infectious Diseases
  73. Antimicrobial management of intra-abdominal infections: Literature's guidelines
    Massimo Sartelli · 2012 · World Journal of Gastroenterology
  74. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates
    Lucas Xavier Bonfietti, Marilena dos Anjos Martins, Maria Walderez Szeszs, S. R. B. S. Pukinskas, Sônia Ueda Purisco, Fabiana Cortez Pimentel, Graziella Hanna Pereira, Dayane Cristina Silva, Lidiane de Oliveira, Márcia de Souza Carvalho Melhem · 2012 · Journal of Medical Microbiology
  75. Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study
    Laura Cuzzolin, Rocco Agostino · 2015 · European Journal of Clinical Pharmacology
  76. Antifungal Susceptibility of 205 Candida spp. Isolated Primarily during Invasive Candidiasis and Comparison of the Vitek 2 System with the CLSI Broth Microdilution and Etest Methods
    Nathalie Bourgeois, L. Dehandschoewercker, Sébastien Bertout, Philippe‐Jean Bousquet, Philippe Rispail, Laurence Lachaud · 2009 · Journal of Clinical Microbiology
  77. A phenotypic small-molecule screen identifies halogenated salicylanilides as inhibitors of fungal morphogenesis, biofilm formation and host cell invasion
    Carlos A. Garcia, Anaïs Burgain, Julien Chaillot, Émilie Pic, Inès Khemiri, Adnane Sellam · 2018 · Scientific Reports
  78. Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
    Vasiliki Soulountsi, Theodoros Schizodimos, Serafeim‐Chrysovalantis Kotoulas · 2021 · Infection
  79. Breakthrough candidaemia in the era of broad-spectrum antifungal therapies
    Cuervo, G., Garcia-Vidal, C., Nucci, M., Puchades, F., Fernández-Ruiz, M., Obed, M., Manzur, A., Gudiol, C., Pemán, J., Aguado, J.M. et al. · 2016 · Clinical Microbiology and Infection
  80. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.
    Marcos-Zambrano, Laura Judith, Escribano, Pilar, Sánchez, Carlos, Muñoz, Patricia, Bouza, Emilio, Guinea, Jesús · 2014 · Antimicrobial Agents and Chemotherapy
  81. Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis
    Ben Y. Parslow, Christopher R. Thornton · 2022 · Microorganisms
  82. Candida glabrata – unique features and challenges in the clinical management of invasive infections
    Andreas Glöckner, Oliver A. Cornely · 2015 · Mycoses
  83. Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective
    Jodi M. Lestner, P. Brian Smith, Michael Cohen‐Wolkowiez, Daniel K. Benjamin, William W. Hope · 2012 · British Journal of Clinical Pharmacology
  84. Invasive candidiasis in pediatric intensive care in Greece: a nationwide study
    Lambrini Vogiatzi, Stavroula Ilia, Georgia Sideri, E. Vagelakoudi, M. Vassilopoulou, Μαρία Σδούγκα, George C. Briassoulis, Ioannis Papadatos, Panayotis Kalabalikis, Lida C. Sianidou et al. · 2013 · Intensive Care Medicine
  85. Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study
    Gregory A. Eschenauer, Peggy L. Carver, Shu‐Wen Lin, Kenneth P. Klinker, Yee‐Chun Chen, Brian A. Potoski, Ryan K. Shields, Cornelius Joseph Clancy, M. Hong Nguyen, Simon W. Lam · 2012 · Journal of Antimicrobial Chemotherapy
  86. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans
    Alexandre Melkoumov, Mathieu Goupil, Fatiha Louhichi, Martine Raymond, Louis de Repentigny, Grégoire Leclair · 2013 · Journal of Antimicrobial Chemotherapy
  87. Central venous catheter (CVC) removal for patients of all ages with candidaemia
    Susanne Janum, Arash Afshari · 2016 · Cochrane Database of Systematic Reviews
  88. Candidemia and invasive candidiasis among hospitalized neonates and pediatric patients
    Rachel L. Harrington, Sylvia L. Kindermann, Qingjiang Hou, Robert J. Taylor, Nkechi E. Azie, David L. Horn · 2017 · Current Medical Research and Opinion
  89. Clinical characteristics and risk factors of ocular candidiasis
    Miki Nagao, Takashi Saito, Shoichi Doi, Gou Hotta, Masaki Yamamoto, Yasufumi Matsumura, Aki Matsushima, Yutaka Ito, Shunji Takakura, Satoshi Ichiyama · 2012 · Diagnostic Microbiology and Infectious Disease
  90. Septic Shock Due to Candidemia: Outcomes and Predictors of Shock Development
    Guzmán · 2011 · Journal of Clinical Medicine Research
  91. Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts
    Howard, Susan J., Livermore, Joanne, Sharp, Andrew, Goodwin, Joanne, Gregson, Lea, Alastruey-Izquierdo, A., Perlin, D. S., Warn, Peter A., Hope, William W. · 2011 · Antimicrobial Agents and Chemotherapy
  92. Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis
    Sobel, Jack · 2013 · Patient Preference and Adherence
  93. Candidaemia in Patients with an Inserted Medical Device
    Cauda, Roberto · 2009 · Drugs
  94. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
    Thomas Richard Rogers, Monica A. Slavin, J. Peter Donnelly · 2011 · British Journal of Haematology
  95. Epidemiology and Antifungal Susceptibilities of Yeasts Causing Vulvovaginitis in a Teaching Hospital
    Soledad Pinto Gamarra, Susana Morano, Catiana Dudiuk, Estefanía Mancilla, María Elena Nardin, Emilce Méndez, Guillermo García‐Effrón · 2014 · Mycopathologia
  96. Diagnostic Usefulness of Differential Time to Positivity for Catheter-Related Candidemia
    Ki–Ho Park, Mi Suk Lee, Sang‐Oh Lee, Sang‐Ho Choi, Heungsup Sung, Mi‐Na Kim, Yang Soo Kim, Jun Hee Woo, Sung‐Han Kim · 2014 · Journal of Clinical Microbiology
  97. The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida
    Russell Edward Lewis, Pierluigi Viale, Dimitrios P. Kontoyiannis · 2012 · Virulence
  98. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients*
    Yves Cohen, Philippe Karoubi, Christophe Adrie, Rémy Gauzit, Thierry Marsepoil, Daniel Zarka, Christophe Clec’h · 2010 · Critical Care Medicine
  99. Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region
    Po‐Ren Hsueh, John R. Graybill, Elliott Geoffrey Playford, Siriorn Paritpokee Watcharananan, Myoung‐don Oh, Kamarudin Jaalam, Shunwei Huang, Vivek Nangia, Asok Kurup, Alexander A Padiglione · 2009 · International Journal of Antimicrobial Agents
  100. Comparison of Three Statistical Methods for Establishing Tentative Wild-Type Population and Epidemiological Cutoff Values for Echinocandins, Amphotericin B, Flucytosine, and Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method
    Emilia Cantón, Javier Pemán, David Hervás, Carmen Íñiguez, David Navarro, Julia Echeverría, José Martínez-Alarcón, Dionisia Fontanals, Bárbara Gomila-Sard, Buenaventura Buendía et al. · 2012 · Journal of Clinical Microbiology